Specifically, SDHB mutations are predominantly associated with multiple tumors, and although heterozygous SDHA pathogenic variants account for less than 1% of all PCC/PGL, SDHB mutations account for most common mutation associated with malignant PCCs (93, 94). Here, SDHA is linked to adrenal gland pheochromocytoma.